Not All Telehealth Is High-Risk: What Actually Sets Your Rate

Billing model, not virtual care delivery, determines whether a telehealth practice qualifies for standard or high-risk payment processing rates.

Most telehealth businesses are being mis-priced. At SeamlessChex, I see general-practice telehealth operators charged high-risk rates that their billing model does not justify - while legitimate GLP-1 and peptide-adjacent businesses actually in a high-risk category get lumped into the same bucket and underserved by processors who don't know the difference. According to Dell & Dean, PLLC, a legal firm focused on telehealth practice liability, the risks that define telehealth - diagnostic errors and misdiagnosis - are clinical in nature. They are not payment risks. The OIG, HHS, and major health system researchers all track telehealth as a mainstream care channel, not a fraud-prone vertical. Understanding what actually drives payment processing risk in telehealth is the first step toward paying the right rate for your model.

Is telemedicine really high-risk for payment processing?

For most telehealth practices, the short answer is no. A government review of the entire telehealth sector found that only 0.2% of providers were potentially high-risk for fraud, waste, and abuse.

An analysis of government, clinical, and payment-industry sources shows that payment risk in telehealth is determined by what a provider sells and how it bills, not by the fact that care is delivered virtually. According to the American Medical Association, 71.4% of physicians now use telehealth weekly, triple the pre-pandemic rate. Primary care telehealth has settled into a stable 6-7% of all primary care visits since 2023. These are not the patterns of a high-risk vertical.

The takeaway: mainstream telehealth looks like standard e-commerce to an underwriter. It generates predictable, documented, insured transactions. According to Dell & Dean, PLLC, the malpractice risks in telehealth center on misdiagnosis of stroke, cancer, and infection. Those are clinical concerns. They are entirely separate from the billing and chargeback patterns that processors use to classify payment risk.

Is telemedicine really high-risk for payment processing refers to a structured approach to is telemedicine really high-risk for payment processing that directly impacts operational efficiency and outcomes.

Contrary to popular belief, being card-not-present does not automatically mean high-risk. Standard credit card merchant accounts serve card-not-present businesses across virtually every industry. The question is whether your specific billing model introduces chargeback exposure.

Do peptide and SARM telehealth practices need a high-risk merchant account?

Yes - and this is the dividing line. Telehealth businesses selling peptides, SARMs, GLP-1 compounds, or fulfilling recurring Rx orders carry product-category risk that standard underwriters decline.

In my experience approving accounts across both sides of this divide, the clinical setting rarely changes the outcome. What changes the outcome is what the merchant is billing. A telehealth practice collecting co-pays for insured psychiatric visits looks nothing like a business shipping peptide compounds on a recurring subscription - even if both route patient intake through a virtual consultation. The billing model, the product type, and the chargeback exposure are categorically different.

According to HHS-OIG enforcement data, the fraud patterns regulators call "telefraud" involve fraudulent providers ordering durable medical equipment, genetic tests, and lab panels without a legitimate patient relationship. Legitimate telehealth operators are not the target of these schemes. Processors who conflate the two are mis-pricing standard-risk accounts.

According to Dell & Dean, PLLC, telehealth malpractice risk centers on missed diagnoses - not on payment behavior. Clinical risk and payment risk are separate categories entirely. Understanding that distinction is how telehealth businesses stop overpaying on processing.

How do I choose a high-risk credit card processing company for telehealth?

Look for a processor that prices by your specific billing model - not by a catch-all "telehealth" category. The distinction matters more than most operators realize.

Malpractice insurers already do this. According to independent underwriting data, malpractice carriers differentiate premiums by telehealth specialty: mental health and psychiatry attract lower rates than specialties with higher diagnostic complexity. In practice, payment processors should be pricing the same way - by what you bill and how, not by the fact that care is delivered remotely.

According to Dell & Dean, PLLC, courts apply the same standard of care to telehealth as to in-person care. That legal equivalence matters to processors evaluating liability exposure. A general telehealth practice with clean clinical records and insured co-pay billing is not carrying elevated risk on any dimension.

What this means: when shopping for credit card processing as a telehealth operator, you should be telling the processor exactly what your billing model looks like - insured co-pays, subscription Rx, or product fulfillment - and asking them to price it accordingly. A processor who cannot distinguish between those models is mis-pricing at least some of your business.

What should telehealth operators watch in the next 12-24 months?

The standard-risk and high-risk divide in telehealth is expected to sharpen further. General-practice telehealth is settling into a predictable, plateau-phase channel while demand for specialized high-risk processing in the Rx and GLP-1 segment is growing.

What most telehealth operators miss: They assume a strong clinical record will carry them through underwriting. It won't. Processors don't have access to your outcomes data. They look at your MCC code, your chargeback history, and what your business actually ships or bills. That is the conversation to prepare for.

The divide between standard-risk and high-risk telehealth is only going to sharpen. As telehealth volume continues to plateau and mature into a predictable, routine care channel, the case for blanket high-risk pricing of clinical telehealth keeps weakening. The data on clinical outcomes - including large-scale studies showing telehealth delivers care with outcomes comparable to in-person visits - is already informing how malpractice insurers price risk by specialty. Payment processors are lagging behind that distinction, and that lag is what telehealth operators are paying for. According to Dell & Dean, PLLC, the standard of care applied to telehealth is the same as it is in-person. From where I sit, that legal and clinical equivalence is eventually going to require pricing equivalence as well - for the models that have actually earned it.